SparkleFresh Fluoride Toothpaste, Sodium Monofluorophosphate 0.76%, a) 17 g tube (NDC 53329-083-9...
FDA Drug Recall #D-0247-2019 — Class II — September 17, 2018
Recall Summary
| Recall Number | D-0247-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | September 17, 2018 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Medline Industries Inc |
| Location | Northfield, IL |
| Product Type | Drugs |
| Quantity | 994,756 tubes |
Product Description
SparkleFresh Fluoride Toothpaste, Sodium Monofluorophosphate 0.76%, a) 17 g tube (NDC 53329-083-92, product number NONTP6I), b) 24 g tube (NDC 53329-083-93, product number NONTP85I), c) 42.5 g (NDC 53329-083-21, product number NONTP15I), d) 24 g tube (NDC 53329-081-93, product number DGN1000), Made in Malaysia for Medline Industries, Inc., Three Lakes Drive, Northfield, IL 60093 USA
Reason for Recall
Microbial Contamination of Non-Sterile Product
Distribution Pattern
Nationwide USA and Puerto Rico
Lot / Code Information
a) Lot 102920C, exp 10/29/2020 and 111220C, exp 11/11/2020; b) 111620D, exp 11/16/2020; c) 111420D, exp 11/14/2020; d) 111720C, exp 11/17/2020
Other Recalls from Medline Industries Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0287-2022 | Class II | Hand Sanitizer Foam (ethyl alcohol), 62% v/v, p... | Nov 8, 2021 |
| D-0624-2021 | Class III | READYPREP CHG, 2% Chlorhexidine Gluconate Cloth... | May 14, 2021 |
| D-0546-2018 | Class II | PVP Scrub Solution, Povidone Iodine, 7.5% (equi... | Feb 15, 2018 |
| D-0271-2018 | Class II | Medline General Purpose Kit, Sterile, Single us... | Sep 21, 2017 |
| D-0277-2018 | Class II | Medline All Purpose Instrument Tray, Sterile. P... | Sep 21, 2017 |
Frequently Asked Questions
Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.